Posts Tagged ‘SPRING’
Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension
Chemomab – latest results from the Open Label Extension of the SPRING clinical trial
Read MoreNew Phase 3 Trial Planned for Nebokitug in PSC
A new trial is planned for PSC
Read MoreSPRING Clinical Trial Update
Clinical Data from Phase 2 SPRING Trial Shows CM-101 Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of PSC.
Read MoreChemomab Therapeutics Receives FDA Fast Track Designation for CM-101 for the Treatment of PSC
Positive news for the SPRING trial investigational drug, CM-101
Read More